Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05835011
Title A Study of Oral Decitabine/Cedazuridine in Combination With Magrolimab in Participants With Intermediate- to Very High-Risk Myelodysplastic Syndromes (MDS)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Astex Pharmaceuticals, Inc.
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.